verapamil has been researched along with Fasciculation in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Fasciculation: Involuntary contraction of the muscle fibers innervated by a motor unit. Fasciculations may be visualized as a muscle twitch or dimpling under the skin, but usually do not generate sufficient force to move a limb. They may represent a benign condition or occur as a manifestation of MOTOR NEURON DISEASE or PERIPHERAL NERVOUS SYSTEM DISEASES. (Adams et al., Principles of Neurology, 6th ed, p1294)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with pre-existing peripheral neuropathy developed generalized fasciculations under verapamil which ceased after discontinuation of the drug." | 7.68 | Fasciculations due to verapamil in a patient with neuropathy. ( Hopf, HC; Röder, R; Thömke, F; Vogt, T, 1990) |
| "Pretreatment with phenytoin, 20 mg/kg, reduced the number of fasciculations to 32% of control without altering contractile strength." | 5.28 | Effects of calcium channel blocking agents on neostigmine-induced fasciculations. ( Dretchen, KL; Henderson, TR; Raines, A, 1989) |
| "A patient with pre-existing peripheral neuropathy developed generalized fasciculations under verapamil which ceased after discontinuation of the drug." | 3.68 | Fasciculations due to verapamil in a patient with neuropathy. ( Hopf, HC; Röder, R; Thömke, F; Vogt, T, 1990) |
| "Pretreatment with phenytoin, 20 mg/kg, reduced the number of fasciculations to 32% of control without altering contractile strength." | 1.28 | Effects of calcium channel blocking agents on neostigmine-induced fasciculations. ( Dretchen, KL; Henderson, TR; Raines, A, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thömke, F | 1 |
| Vogt, T | 1 |
| Röder, R | 1 |
| Hopf, HC | 1 |
| Raines, A | 1 |
| Henderson, TR | 1 |
| Dretchen, KL | 1 |
2 other studies available for verapamil and Fasciculation
| Article | Year |
|---|---|
Fasciculations due to verapamil in a patient with neuropathy.
Topics: Aged; Arrhythmias, Cardiac; Fasciculation; Humans; Male; Peripheral Nervous System Diseases; Verapam | 1990 |
Effects of calcium channel blocking agents on neostigmine-induced fasciculations.
Topics: Animals; Calcium Channel Blockers; Electric Stimulation; Facial Muscles; Fasciculation; Male; Neosti | 1989 |